SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammation.
Liberale L, Kraler S, Puspitasari YM, Bonetti NR, Akhmedov A, Ministrini S, Montecucco F, Marx N, Lehrke M, Hartmann NK, Beer JH, Wenzl FA, Paneni F, Lüscher TF, Camici GG.
Liberale L, et al. Among authors: ministrini s.
Cardiovasc Res. 2023 May 2;119(3):843-856. doi: 10.1093/cvr/cvac126.
Cardiovasc Res. 2023.
PMID: 35993135
Clinical Trial.